Optimizing Fall-risk Prediction in Older Adults With Cancer

The Washington University

Status: Completed

Conditions: Cancer

Treatments: Other: Follow-up Healthcare Provider Assessment; Other: Baseline Healthcare Provider Assessment; Other: Follow-up Participant Assessment; Other: Baseline Participant Assessment; Other: End-of-study Participant Assessment; Other: End-of-study Healthcare Provider Assessment

Study type: Observational

Funder types: Other

Identifiers

NCT02912273

201609049

Details and patient eligibility

About

To establish the optimal strategy of fall-risk assessment to predict falls in older adults receiving cancer therapy.

Enrollment: 227 patients

Sex: All

Ages: 65+ years old

Volunteers: No Healthy Volunteers

Inclusion criteria

• Age ≥65
• Receiving systemic cancer therapy, including conventional chemotherapy, novel/targeted agents or hormonal agents (e.g. anti-estrogen or anti-androgen) OR will begin systemic therapy within the next 4 weeks.
• Estimated life expectancy >1 year
• Anticipated to receive ongoing care at Siteman Cancer Center and its satellite sites
• Able to understand and willing to sign an IRB-approved written informed consent document

Exclusion criteria

• Unable to read and understand English

Trial design

227 participants in 1 patient group

Fall Risk Assessment Group

Description:

-Participants will complete baseline primarily self-administered cancer-specific geriatric assessments and measures of neuropathy and pain, an abbreviated geriatric assessment with each follow-up clinic visit (generally every 3-4 weeks in patients receiving systemic therapy) for 6-months of follow-up and a final end-of-study assessment.

Treatment:

Other: Baseline Participant Assessment

Other: End-of-study Healthcare Provider Assessment

Other: End-of-study Participant Assessment

Other: Follow-up Healthcare Provider Assessment

Other: Follow-up Participant Assessment

Other: Baseline Healthcare Provider Assessment